[1]Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[2]Fisher B, Anderson S,Bryant J, et al. Twenty-year follow-up of arandomized trial comparing total mastectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med,2002,347(16): 1233-1241.
[3]Veronesi U, Cascinelli N,Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J].N Engl J Med,2002,347(16): 1227-1232.
[4]徐东.早期乳腺癌保乳手术对乳腺癌患者远期疗效的影响[J].现代诊断与治疗, 2017, 28(17): 3266-3267.
[5]范明江,日斯白克·阿不都卡德尔,阿布都沙塔尔·吐尔地.前哨淋巴结活检与腋窝淋巴结清扫对早期乳腺癌患者术后恢复及并发症的影响[J].实用癌症杂志, 2020, 35(1): 145-148.
[6]Fisher B, Bauer M, Margolese R, et al. 5-year results of a randomized clinical-trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast-cancer[J].N Engl J Med, 1985, 312(11): 665-673.
[7]Umberto Veronesi, Roberto Zucali, Alberto Luini. Local-control and survival in early breast-cancer—The Milan Trial [J].Int JRadiat Oncol Biol Phys, 1986, 12:717-720.
[8]Corradini S, Reitz D, Pazos M, et al. Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases[J]. Cancers,2019, 11(2), 160:1-13.
[9]梁燕, 姜军.乳腺癌的区域外科治疗[J].中国普外基础与临床杂志, 2019, 26(12): 1398-1402.
[10]中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J].中国癌症杂志, 2019, 29(8): 609-680.
[11]柳剑英, 步宏.保乳切缘的病理学评估[J]. 中国普外基础与临床杂志,2018, 25(2):134-137
[12]Vos EL, Siesling S, Baaijens MHA, et al. Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival[J]. Breast Cancer Res Treat,2017,164(1):157-167.
[13]Romics L Jr, Chew BK, Weiler-Mithoff E, et al. Ten-year follow-up of skin-sparing mastectomy followed by immediate breast reconstruction[J]. Br J Sur, 2012, 99(6): 799-806.
[14]de Boniface J, Frisell J, Bergkvist L,et al. Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation [J]. Br J Surg, 2018,105(12):1607-1614.
[15]孟亚秋,徐晓帆,顾 军,等.术中放疗在早期乳腺癌保乳手术中的应用[J].医学研究生学报,2017,30(5):534-536.
[16]凡庆东,张在鸿,杨日高,等.蓝染料示踪早期乳腺癌前哨淋巴结活检52例临床分析[J].东南国防医药,2013,15(3):288-289.
[17]章焱华, 李文祥, 桑剑锋.吲哚菁绿荧光技术应用于乳腺癌前哨淋巴结活检的可行性研究进展[J]. 实用癌症杂志, 2019, 34(10): 1738-1740.
[18]李文远, 赵永娜, 鞠卫东, 等. 吲哚菁绿荧光法在乳腺癌前哨淋巴结活检中的临床效果研究[J]. 中国实用医药, 2020, 15(4): 14-16.
[19]史曼曼, 陈 创, 李娟娟, 等. 纳米炭在乳腺癌治疗中的临床应用进展[J]. 肿瘤学杂志, 2019, 25 (1): 12-16.
[20]屠俊浩, 张浩, 陆奕含, 等.纳米炭悬液在乳腺癌前哨淋巴结活检中的应用[J]. 中华实验外科杂志, 2015, 32(12): 3147-3150.
[21]Lucci A, McCall LM, Beitsch PD, et al.Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011[J].J Clin Oncol, 2007, 25(24): 3657-3663.
[22]唐小乔, 苏磊, 桑剑锋. 乳腺癌改良根治术后上肢淋巴水肿与腋窝淋巴结阳性率的相关性分析[J].中华普外科手术学杂志, 2020, 14(1):74-77.
[23]扈杰杰,俞洋.乳腺癌Ⅲ水平腋窝淋巴结清扫的研究进展[J].中华乳腺病杂志, 2019, 13(5): 301-304.
[24]Roy P, Leizorovicz A, Villet R, et al. Systematic versus sentinellymphnodedriven axillarylymphnode dissection in clinically nodenegative patients with operable breast cancer. Results of the GFGS01 randomized trial[J]. Breast Cancer Res Treat, 2018, 170(2):303-312.
[1]凡庆东,张在鸿,杨日高,等.蓝染料示踪早期乳腺癌前哨淋巴结活检52例临床分析[J].医学研究与战创伤救治(原医学研究生学报),2013,15(03):288.[doi:10.3969/j.issn.1672-271X.2013.03.026]